LivaNova (Nasdaq:LIVN) announced today that its board of directors appointed Brooke Story to its board as a new director.
Story currently serves as worldwide president, integrated diagnostic solutions at BD (NYSE:BD). Her appointment to LivaNova’s board is effective today, Sept. 15, 2022. She will also be a member of the board’s nominating and corporate governance committee.
The industry veteran joined BD in her current role in April 2021. Before that, she spent 15 years at medtech giant Medtronic across a range of roles. Prior to her departure, she held the role of president of Medtronic’s pelvic health and gastric therapies. She also spent time early in her career in sales at Johnson & Johnson.
“Over the course of her career, Brooke has excelled in helping large medical device corporations inspire their teams, mentor and develop talent, and deliver economic value,” said William Kozy, chair of the LivaNova board. “Her insight will prove valuable to the Board as we work to guide the company toward continued growth and success.”
Story joins nine other directors who comprise the LivaNova board.
“LivaNova has a clear and demonstrated commitment to patients’ quality of life,” said Story. “I look forward to working with the Board to support the company’s innovation and ongoing delivery of life-changing medical technologies.”